Theorem Clinical Research

Global News

Mallinckrodt appoints new leaders following completion of Questcor acquisition

Thursday, August 28, 2014 02:07 PM

Mallinckrodt, an Ireland-based global specialty pharmaceutical company, has announced that Gary Phillips, M.D., current senior vice president and chief strategy officer, has been appointed senior vice president and president of the company’s autoimmune and rare disease business, which includes the commercial organization supporting H.P. Acthar Gel.

More... »


Report: Pharma crosses new frontiers with global tiered pricing strategies

Wednesday, August 27, 2014 01:15 PM

Despite the adoption of tiered pricing strategies by pharmaceutical companies around the world, there is only a tenuous correlation between the prices of pharmaceutical products and the local economic conditions of the countries where they are launched, according to a comprehensive new study by IHS, a global source of critical information and insight, headquartered in Englewood, Colo.

More... »


Medtronic acquires Sapiens Steering Brain Stimulation

Wednesday, August 27, 2014 01:12 PM

Medtronic, a Minneapolis, Minn., medical technology provider, has acquired Sapiens Steering Brain Stimulation (Sapiens SBS), a Netherlands-based, privately held developer of deep brain stimulation (DBS) technologies, for approximately $200 million in cash.

More... »

Pfizer, Merck to collaborate on anti-cancer combination regimen

Wednesday, August 27, 2014 10:01 AM

Pfizer and Merck have entered into an agreement to explore the therapeutic potential of the combination of Pfizer’s crizotinib (XALKORI) with Merck’s investigational anti-PD-1 antibody pembrolizumab, in a phase Ib clinical study evaluating the safety and tolerability of the combination in patients with ALK-positive advanced or metastatic non-small cell lung cancer (NSCLC).  The financial terms of the agreement have not been disclosed. 

More... »

Expression Analysis, Illumina launch 2014 grant program

Monday, August 25, 2014 02:13 PM

Expression Analysis (EA), a Quintiles company based in Research Triangle Park, N.C., is co-sponsoring a grant program that provides scientists with leading-edge products and services to advance genomics research.

More... »

Covidien acquires Reverse Medical

Monday, August 25, 2014 02:11 PM

Covidien, a Dublin, Ireland-based global healthcare products company and manufacturer of medical devices and supplies, has acquired California-based Reverse Medical, a privately held medical device company focused on expanding the management of vascular disease. Financial terms of the transaction have not been disclosed.

More... »

OncoSynergy launches ebola treatment crowdfunding campaign

Monday, August 25, 2014 02:09 PM

OncoSynergy, a University of California San Francisco spinoff focused on addressing unmet needs in oncology, particularly orphan cancers, has launched a crowdfunding campaign to fund a study testing its experimental cancer drug, OS2966, for ebola infection.

More... »

Cancer Genetics completes acquisition of BioServe India

Monday, August 25, 2014 02:06 PM

Cancer Genetics (CGI), a Rutherford, N.J.-based, DNA-based cancer diagnostics provider, has completed the acquisition of BioServe Biotechnologies, a premier genomics services provider serving the research and clinical markets in India.

More... »

Immune Targeting Systems, WCCT Global partner on influenza

Monday, August 25, 2014 02:04 PM

Immune Targeting Systems (ITS), a U.K. company specializing in the development of novel T cell immune therapies, has developed a new T cell vaccine (Flunisyn) designed to protect humans from all strains of seasonal and pandemic influenza A. ITS has sold the strain to California-based CRO WCCT Global for further development.

More... »

Roche to acquire InterMune for $8.3 billion

Monday, August 25, 2014 02:02 PM

Roche and InterMune have entered into a definitive merger agreement under which Roche will fully acquire InterMune for $74 per share in cash, for a total transaction value of $8.3 billion on a fully diluted basis.

More... »

`
CenterWatch Data Library
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 29

WCG sees ePharmaSolutions’ clinical trial portal as the next step in the data evolution, company mission

Cutting-edge advertising can ‘break through the clutter’ for successful patient recruitment

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

September

Today's fastest, most economical sponsors
Standout sponsors reveal how they shorten regulatory, clinical cycle times

From the trenches: Sites' eye view of state of the industry
CW’s first site focus groups uncover frustration with 'progress,' but a passion for their mission

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

August

Reality of costs and impact rain on Sunshine Act
Concerns mount over compliance burden on CROs, sponsors, unanticipated consequences for research

Cloud computing expanding into all areas of clinical trial conduct
Benefits outweigh the complexities, challenges of finding right vendors

Already a subscriber?
Log in to your digital subscription.

Purchase the August issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs